S1817 — Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment
Last action — In Senate Committee
-
1Introduced
-
2In Committee
-
3Passed Senate
-
4Passed Assembly
-
5To Executive
-
6Enacted
This bill has been introduced in the Senate. Introduced January 14, 2025. It must pass committee before a floor vote.
Next likely step: a committee referral and hearing.
Odds of enactment
Low chanceBased on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.
Upgrade to see the exact probability and what's driving it.
A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.
Prognosis
-
Introduced
Current position in the legislative process.
-
1 sponsor
1 primary, 0 co-sponsors signed on.
-
Cleared a recorded vote
Passed 1 recorded vote so far.
Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.
Summary
Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction.
Bill Text
- Full text View text Current
Action History
-
REPORTED AND COMMITTED TO FINANCE
-
REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS
-
REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS
Sponsors
- Nathalia Fernandez · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 218 not signed on
Sponsors (1)
Co-sponsors (0)
None.
Not signed on (218)
218 members have not signed on to this bill.
Show all 218 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Votes
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| Unaffiliated | 6 | 0 | 0 | 1 |
| Total | 6 | 0 | 0 | 1 |
| % of votes cast | 86% | 0% | 0% | 14% |
How each member voted (7)
| Member | Party | Vote |
|---|---|---|
| Erik Bottcher | — | Yea |
| Gustavo Rivera | — | Yea |
| Monica Martinez | — | Yea |
| Nathalia Fernandez | — | Yea |
| Pete Harckham | — | Yea |
| Peter Oberacker | — | Not Voting |
| Robert Rolison | — | Yea |
Subjects
Frequently asked questions
- What does S1817 do?
- Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction.
- Who sponsors S1817?
- S1817 is sponsored by Nathalia Fernandez.
- What is the current status of S1817?
- This bill has been introduced in the Senate. Introduced January 14, 2025. It must pass committee before a floor vote.
- Where can I track S1817?
- Track S1817 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on S1817
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of S1817
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →